Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease (Q38629322)

4 September 2017

Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease (English)

1 reference

4 September 2017

1 reference

Merlin C Thomas

1

0 references

Paul Zimmet

object named as

Paul Zimmet

series ordinal

3

0 references

author name string

Mark E Cooper

series ordinal

2

1 reference

PubMed ID

26553517

4 September 2017

language of work or name

English

0 references

publication date

10 November 2015

1 reference

Nature Reviews Nephrology

4 September 2017

1 reference

4 September 2017

12

1 reference

4 September 2017

73-81

1 reference

4 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2015.173

4 September 2017

0 references

cites work

Diabetes: a 21st century challenge

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

The high prevalence of diabetes mellitus on a Central Pacific Island

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Explaining the increase of diabetes prevalence and plasma glucose in Mauritius

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Obesity and type 2 diabetes in Sub-Sahara Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Increasing prevalence of type 2 diabetes in Chinese adults in Shanghai.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Global estimates of diabetes prevalence for 2013 and projections for 2035.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Economic costs of diabetes in the U.S. in 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Chronic kidney disease: global dimension and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Multimorbidity due to diabetes mellitus and chronic kidney disease and outcomes in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

21 January 2018

Diabetic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Temporal trends in the prevalence of diabetic kidney disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Renal Dysfunction in the Presence of Normoalbuminuria in Type 2 Diabetes: Results from the DEMAND Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Obesity and kidney disease in type 1 and 2 diabetes: an analysis of the National Diabetes Audit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

An observational, cross-sectional study to assess the prevalence of chronic kidney disease in type 2 diabetes patients in India (START -India).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Risk factors for the development of albuminuria and renal impairment in type 2 diabetes--the Swedish National Diabetes Register (NDR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Low incidence of end-stage renal disease and chronic renal failure in type 2 diabetes: a 10-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Regression of microalbuminuria in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Chronic kidney disease in type 2 diabetes: lessons from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Kidney disease and increased mortality risk in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Nonalbuminuric renal insufficiency in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Standards of medical care in diabetes--2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Impact of estimated GFR reporting on patients, clinicians, and health-care systems: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Referrals for chronic kidney disease: real problem or nuisance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Automated reporting of estimated glomerular filtration rate alters referral patterns to a nephrology clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Impact of estimated GFR reporting on late referral rates and practice patterns for end-stage kidney disease patients: a multilevel logistic regression analysis using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Increases in renal replacement therapy in Australia and New Zealand: understanding trends in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Chronic kidney disease perspectives in Japan and the importance of urinalysis screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

End-stage renal disease in India and Pakistan: burden of disease and management issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Risks of rapid decline renal function in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Stabilized incidence of diabetic patients referred for renal replacement therapy in Denmark.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

The Danish National Diabetes Register: trends in incidence, prevalence and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Diabetic CKD/ESRD 2010: a progress report?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Economic and social implications of aging societies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Type 2 diabetes in youth: epidemiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Type 2 diabetes in young Indigenous Australians in rural and remote areas: diagnosis, screening, management and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

A clinical trial to maintain glycemic control in youth with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

High burden of kidney disease in youth-onset type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Acute and chronic complications of type 2 diabetes mellitus in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Changing course of diabetic nephropathy in the Pima Indians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Prevalence and control of diabetes in Chinese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Increased prevalence of albuminuria among non-European peoples with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Complications and cardiovascular risk factors in South Asians and Europeans with early-onset type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Increased incidence of end-stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Rates of progression to end stage renal failure in nephropathy secondary to type 1 and type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Intrauterine diabetes exposure and the risk of renal disease in diabetic Pima Indians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

A basis for accelerated progression of diabetic nephropathy in Pima Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Birth weight and renal disease in Pima Indians with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Kidney volume, blood pressure, and albuminuria: findings in an Australian aboriginal community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Is glycemic control improving in U.S. adults?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Prevalence of hypertension and dyslipidemia and their associations with micro- and macrovascular diseases in patients with diabetes in Taiwan: an analysis of nationwide data for 2000-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Serum lipids and the progression of nephropathy in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Hypertriglyceridemia Is Independently Associated with Renal, but Not Retinal Complications in Subjects with Type 2 Diabetes: A Cross-Sectional Analysis of the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Effects of fibrates in kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Effects of lowering LDL cholesterol on progression of kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Temporal trends in BMI among adults with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

The link between obesity and albuminuria: adiponectin and podocyte dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

The incidence of albuminuria after bariatric surgery and usual care in Swedish Obese Subjects (SOS): a prospective controlled intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Causes of the change in the rates of mortality and severe complications of diabetes mellitus: 1992-2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Prevalence of chronic kidney disease among individuals with diabetes in the SUPREME-DM Project, 2005-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Improved survival and renal prognosis of patients with type 2 diabetes and nephropathy with improved control of risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

New approaches to the treatment of nephropathy in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

The gap between estimated incidence of end-stage renal disease and use of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Obesity and Risk for Chronic Renal Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Globalization of diabetes: the role of diet, lifestyle, and genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Diabetes in South Asians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Racial differences in estimated GFR decline, ESRD, and mortality in an integrated health system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Racial and ethnic variations in albuminuria in the US Third National Health and Nutrition Examination Survey (NHANES III) population: associations with diabetes and level of CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

South-Asian Type 2 Diabetic Patients Have Higher Incidence and Faster Progression of Renal Disease Compared With Dutch-European Diabetic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Glomerular Filtration Rate, Cardiorenal End Points, and All-Cause Mortality in Type 2 Diabetic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Diabetes mellitus in American (Pima) Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Factors associated with increased healthcare costs in Medicare Advantage patients with type 2 diabetes enrolled in a large representative health insurance plan in the US

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

The global burden of chronic kidney disease: how valid are the estimates?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Diabetic kidney disease: act now or pay later

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Changes in diabetes-related complications in the United States, 1990-2010

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Evolution of the incidence of chronic kidney disease Stage 5 requiring renal replacement therapy in the diabetic population of Catalonia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Inappropriate prescribing in elderly people with diabetes admitted to hospital.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

A 5-year-old girl with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Role of glycemic control and blood pressure in the development and progression of nephropathy in elderly Japanese NIDDM patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Diabetes and hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.173

Medical costs associated with type 2 diabetes complications and comorbidities

31 March 2020

1 reference

12 December 2020

Elevated blood pressure predicts the development of persistent proteinuria in the presence of poor glycemic control, in patients with type I diabetes

1 reference

12 December 2020

Chronic kidney disease in the Arab world: a call for action

1 reference

12 December 2020

Controversies in chronic kidney disease staging

1 reference

12 December 2020

Prevalence of Chronic Kidney Disease in Adults with Type 2 Diabetes Mellitus.

1 reference

12 December 2020

The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study).

1 reference

12 December 2020

The epidemiology of diabetes in Polynesians and Europeans in New Zealand and the Pacific

1 reference

12 December 2020

Diabetes mellitus survey in Shanghai

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2015.173

1 reference

PubMed ID

26553517

Dimensions Publication ID

4 September 2017

0 references

1 reference

PubMed ID

26553517